Foster City, CA – Gilead Sciences has announced the acquisition of Arcellx (https://www.arcellx.com/). According to the company announcement, Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. The company is committed to advancing innovative medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis, COVID-19, and cancer. In 2025, Gilead announced a planned $32 billion investment to further strengthen its U.S. footprint to power the next era of discovery, job creation and public health preparedness while continuing to invest globally to ensure patients everywhere benefit from its scientific innovation. Gilead operates in more than 35 countries worldwide, with headquarters in Foster City, Calif.

To learn more about Gilead Sciences, visit https://www.gilead.com/
LinkedIn Page: https://www.linkedin.com/company/gilead-sciences/

Company Contact:

Gilead Sciences
333 Lakeside Drive
Foster City, CA 94404
650-574-3000

SOURCE: http://www.intelligence360.io
Copyright (c) 2026 SI360 Inc. All rights reserved.